VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
KONE Oyj vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
KONE Oyj
KNEBV · Nasdaq Helsinki
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 63 / 100 for KONE Oyj).
- Segment focus: KONE Oyj has 3 segments (40.6% in New Building Solutions); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: KONE Oyj has 8 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
KONE Oyj
New Building Solutions
Elevator, escalator and automatic building door new equipment (new installations)
Global
Property developers and general contractors
OEM + project installation
40.6%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
KONE Oyj strengths
Sanofi strengths
Segment mix
KONE Oyj segments
Full profile >New Building Solutions
Oligopoly
Service (maintenance & repairs)
Competitive
Modernization
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.